Changchun Intellicrown Pharmaceutical Co. LTD
Changchun Intellicrown Pharmaceutical Co. LTD
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| To Evaluate the Tolerability, Pharmacokinetics, and Pharmacodynamics of IMM-H014 in Patients With MASH | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Not yet recruiting | Phase 1 / Phase 2 | 2025-06-13 | NCT07016633 | |
| ZZ06 in Adult Patients With Advanced Solid Tumor Malignancies | Advanced EGFR Positive Solid Tumor | Recruiting | Phase 1 | 2025-06-10 | NCT04412616 | |
| To Evaluate the Safety, Tolerability, Pharmacokinetics and Food Effects of IMM-H014 in Healthy Subjects | Digestive System Diseases, fatty liver disease, liver disorder, metabolic dysfunction-associated steatotic liver disease | Recruiting | Phase 1 | 2025-04-11 | NCT06216041 |